Automatic Data Processing (ADP)
$138.10 0.00 (0.00%)
5:12 EDT ADP Stock Quote Delayed 30 Minutes
Previous Close $138.10
Market Cap 60.84B
PE Ratio 34.53
Volume (Avg. Vol.) 1
Day's Range 138.10 - 138.10
52-Week Range 103.11 - 182.32
Dividend & Yield 2.64 (1.91%)
ADP Stock Predictions, Articles, and Automatic Data Processing News
- From InvestorPlace
- From the Web
This week, 4 IT Services stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
With high yields and exceptional growth, these dividend stocks pack a wallop and are some of the best investments to make for the New Year.
3 Big Stock Charts for Wednesday: Best Buy Co Inc (BBY), Darden Restaurants, Inc. (DRI) and Automatic Data Processing (ADP)
November has been good to Best Buy (BBY), Darden (DRI) and ADP (ADP), with positive earnings reports combined with solid technicals.
Nine notable dividend stocks raised their payouts this week, including HP (HPQ) and Automatic Data Processing (ADP).
P/E isn't the only way to suss out disasters in the making. Here, free cash flow will lead us to some loser S&P 500 stocks to get rid of.
Looking at the stocks we cover at Dividend Channel, ManTech International, Automatic Data Processing, and TELUS will go ex-dividend on 9/7/16
A study of analyst recommendations shows that International Business Machines is the #25 broker pick on average in the Dow Jones
During these times it pays to stay on top of the latest profit opportunities. Start with these updated Portfolio Grader ratings
The Bank of England cut rates and also announced expanded QE and corporate bond buybacks. Markets are higher on the news
This week markets sloshed around on a handful of mixed economic reports. These data impact on our portfolios, so let's go over some key numbers
This week's vast array of global and domestic data may go a long way in providing answers on the market's summer prospects
In this low interest rate environment, dividends are still looking great, but investors still need to exercise caution, and I'm here to help...
Instead of my usual comprehensive economic digest, I'm going to focus on the US jobs picture which is moving the markets today
Markets continue to fall after this mornings's ADP report showed continued slowdown in job creation in the US.
From The Motley Fool
From Seeking Alpha
Adverum Biotechnologies (ADVM -9.8%) has announced positive new interim data from Cohorts 1-4 of the OPTIC Phase 1 trial of ADVM-022 intravitreal injection gene therapy in patients with wet age-related macular degeneration, who require frequent anti-VEGF injections.Data showed treatment response from both high and low doses of ADVM-022, and demonstrated long-term durability beyond 15 months from a single IVT injection with zero anti-VEGF rescue injections in patients from Cohort 1.On safety front, ADVM-022 was well tolerated across all cohorts with encouraging safety data from Cohort 4; though ocular inflammation was observed that was responsive to steroid eye drops.With the OPTIC enrollment now complete, the company expects to present clinical data from Cohorts 1 to 4 by the end of this year.It plans to initiate a pivotal Phase 3 clinical trial in mid-2021, a timeline that investors may be reacting to.The company has initiated process scale-up from 200L to 1000L scale to support the future commercial product launch of ADVM-022.Also, expects to present clinical data from INFINITY Phase 2 data of ADVM-022 in diabetic macular edema in 2H of 2021.
From Talk Markets
Navellier RatingsPowered by Portfolio Grader